All In MedTech

FDA Clearance Tracker · P190016-S007

Tula® System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 1, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 1, 2024

Approved

Time to decision

302 days

Received Apr 5, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P190016-S007
Device name
Tula® System
Applicant location
Menlo Park, CA
Received
Apr 5, 2023
Decided
Feb 1, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P190016

Device type

Device class
Class III

Every decision under product code QJA

FDA's approval statement

As written in FDA's record.

which requested approval for modifications to the design of the Iontophoresis System (IPS) Earset and Tube Delivery System (TDS) components of the Tula System, collectively described as the next generation (“Tula Gen 2”), as well as modifications to the Tula System packaging configuration and tray sealing. Finally, your supplement requested approval for a Predetermined Change Control Plan (PCCP) for an alternate microcontroller component.

Source documents

Other decisions for Tusker Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.